Structure and function of plasminogen activator inhibitor-2: An intracellular serine proteinase inhibitor modulating apoptosis (Review)

International Journal of Oncology

Volumn 11, Issue 3, 1997, Pages 557-570

  Jensen, Poul Henning ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Apoptosis; Plasminogen activator inhibitor 2; Serine proteinase inhibitor

Indexed keywords

MESSENGER RNA; OVALBUMIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CANCER; CELL SURVIVAL; COVALENT BOND; HUMAN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; STRUCTURE ACTIVITY RELATION;

EID: 0030841058     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Huber R and Carrell RW: Implications of the three-dimensional structure of alfal-antitrypsin for structure and function of serpins. Biochem J 28: 8951-8966, 1989.
2. Potempa J, Korzus E and Travis J: The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269: 15957-15960, 1994.
3. Becerra SP, Sagasti A, Spinella P and Notario V: Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem 270: 25992-25999, 1995.
4. Steele FR, Chader GJ, Johnson LV and Tombran Tink J: Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 90: 1526-1530, 1993.
5. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS and Pickup DJ: Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69: 597-604, 1992.
6. Brooks MA, Ali AN, Turner PC and Moyer RW: A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J Virol 69: 7688-7698, 1995.
7. Kumar S and Baglioni C: Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 266: 20960-20964, 1991.
8. Dickinson JL, Bates EJ, Ferrante A and Antalis TM: Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 270: 27894-27904, 1995.
9. Macen JL, Garner RS, Musy PY, Brooks MA, Turner PC, Moyer RW, McFadden G and Bleackley RC: Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc Natl Acad Sci USA 93: 9108-9113, 1996.
10. Stein PE, Leslie AG, Finch JT, Turnell WG, McLaughlin PJ and Carrell RW: Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 347: 99-102, 1990.
11. Samia JA, Alexander SJ, Horton KW, Auron PE, Byers MG, Shows TB and Webb AC: Chromosomal organization and localization of the human urokinase inhibitor gene: perfect structural conservation with ovalbumin. Genomics 6: 159-167, 1990.
12. Remold O: The ovalbumin family of serpin proteins. FEBS Lett 315: 105-108, 1993.
13. Åstedt B, Lecander I and Ny T: The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1: 203-208, 1987.
14. Bachmann F: The enigma PAI-2. Gene expression, evolutionary and functional aspects. Thromb Haemost 74: 172-179, 1995.
15. Kruithof EK, Baker MS and Bunn CL: Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86: 4007-4024, 1995.
16. Kotwal GJ and Moss B: Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine proteinase inhibitor superfamily. J Virol 63: 600-606, 1989.
17. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994.